Skip to main content
. 2023 Sep 18;5:1133556. doi: 10.3389/frph.2023.1133556

Table 4B.

Treatment emergent metabolic syndrome at any time point: NAMSAL.

TDF/FTC + DTG n (%) TDF/FTC/EFV n (%) p - χ2
All participants 41/287 (14%) 14/271 (5%) 0.00
Female 19/182 (10%) 13/185 (7%) 0.33
Male 22/105 (21%) 1/86 (1%) 0.00